Julius M. Wilder, Ph.D.
Affiliations: | 2007 | Duke University, Durham, NC |
Area:
Demography, Public and Social Welfare, Ethnic and Racial Studies, Black StudiesGoogle:
"Julius Wilder"Parents
Sign in to add mentor| Angela M. O'Rand | grad student | 2007 | Duke | |
| (Socioeconomic status as a fundamental cause of mortality in African Americans: The Pitt County study.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Goldberg D, Wilder J, Terrault N. (2024) Health disparities in cirrhosis care and liver transplantation. Nature Reviews. Gastroenterology & Hepatology |
| Henson JB, Wilder JM, Kappus MR, et al. (2020) Transplant Outcomes in Older Patients with Nonalcoholic Steatohepatitis Compared to Alcohol-Related Liver Disease and Hepatitis C. Transplantation |
| Spiritos Z, Salvador S, Mosquera D, et al. (2019) Acute Intermittent Porphyria: Current Perspectives And Case Presentation. Therapeutics and Clinical Risk Management. 15: 1443-1451 |
| Proeschold-Bell RJ, Evon DM, Yao J, et al. (2019) A randomized controlled trial of an integrated alcohol reduction intervention in patients with hepatitis C infection. Hepatology (Baltimore, Md.) |
| Wilder J, Choi SS, Moylan CA. (2019) Evaluation for Fibrosis After Cure of Hepatitis C-Reply. Jama. 321: 1535 |
| Mosquera DM, Wilder J, Ellis A, et al. (2019) 301. Risk of Virologic Failure with Antiretroviral Switches in HIV/HCV Co-infections Open Forum Infectious Diseases. 6 |
| Wilder J, Choi SS, Moylan CA. (2018) Vibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic Fibrosis. Jama |
| Patel YA, Henson JB, Wilder JM, et al. (2018) The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. Clinical Transplantation. e13388 |
| Proeschold-Bell RJ, Evon DM, Makarushka C, et al. (2018) The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial. Contemporary Clinical Trials |
| Clement ME, Collins LF, Wilder JM, et al. (2018) Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure. Infectious Disease Clinics of North America. 32: 407-423 |